[Reperfusion in acute ischaemic stroke: present and future].

M Herrera1, J Gállego, R Muñoz

  • 1Servicio de Neurología, Hospital de Navarra, Pamplona, Spain. isasima@hotmail.com

Summary

Acute ischemic stroke treatment focuses on reperfusion and neuroprotection. Current thrombolytic therapy, intravenous Recombinant Tissue Plasminogen Activator (rtPA), has limitations, prompting exploration of new strategies to improve outcomes.